| |
| |
|
| Insider
Information: |
Coats Lonnel |
| Relationship: |
|
| City: |
The Woodlands |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,109,080 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,690,143 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,109,080 |
|
|
| Total
Value |
$2,690,143 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
6
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
6.0
|
0.0
|
| Percentage
Gain/Loss : |
 25.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lexicon Pharmaceuticals Inc |
LXRX |
Chief Executive Office... |
2024-02-28 |
1,098,068 |
2016-02-29 |
0 |
Premium* |
|
|
Blueprint Medicines Corp |
BPMC |
|
2023-06-21 |
11,012 |
2019-08-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-02-28 |
4 |
D |
$2.62 |
$160,792 |
D/D |
(61,371) |
1,098,068 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
245,080 |
1,159,439 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-11-16 |
4 |
B |
$1.05 |
$94,797 |
D/D |
90,000 |
914,359 |
2.81 |
% |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-11-10 |
4 |
B |
$1.01 |
$10,100 |
D/D |
10,000 |
824,359 |
2.81 |
% |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-06-29 |
4 |
B |
$2.16 |
$21,600 |
D/D |
10,000 |
814,359 |
2.81 |
% |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-06-26 |
4 |
B |
$2.18 |
$21,792 |
D/D |
10,000 |
804,359 |
2.81 |
% |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-06-23 |
4 |
B |
$2.50 |
$24,950 |
D/D |
10,000 |
794,359 |
2.81 |
% |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-06-22 |
4 |
B |
$2.31 |
$92,400 |
D/D |
40,000 |
784,359 |
2.81 |
% |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2023-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,600 |
11,012 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
209,327 |
795,330 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-02-28 |
4 |
D |
$2.17 |
$110,607 |
D/D |
(50,971) |
744,359 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
|
– • – |
2022-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
2,600 |
8,412 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2022-02-28 |
4 |
D |
$2.85 |
$136,951 |
D/D |
(48,053) |
586,003 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
197,343 |
634,056 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
5,812 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CEO |
• • – |
2021-02-28 |
4 |
D |
$7.19 |
$395,723 |
D/D |
(55,038) |
436,713 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CEO |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
192,885 |
491,751 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
3,562 |
0 |
- |
|
| BPMC |
Blueprint Medicines Corp |
Director |
– • – |
2020-06-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,312 |
1,312 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CEO |
• • – |
2020-02-28 |
4 |
D |
$2.77 |
$125,536 |
D/D |
(45,320) |
298,866 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CEO |
• • – |
2020-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
116,647 |
344,186 |
0 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CEO |
• • – |
2019-09-18 |
4 |
B |
$3.10 |
$155,000 |
D/D |
50,000 |
227,539 |
2.81 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CEO |
• • – |
2019-09-17 |
4 |
B |
$3.12 |
$156,403 |
D/D |
50,000 |
177,539 |
2.81 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CEO |
• • – |
2019-08-19 |
4 |
B |
$1.40 |
$4,194 |
D/D |
3,000 |
127,539 |
2.73 |
- |
|
| LXRX |
Lexicon Pharmaceuticals I... |
President and CEO |
• • – |
2019-08-16 |
4 |
B |
$1.33 |
$49,835 |
D/D |
37,000 |
124,539 |
2.81 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
